Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Cellebrite (CLBT) is trading at $11.20, up 1.17% on the day. Its market value of $2.82B makes it the 2546th largest of the 3132 companies we follow.
The stock's 52-week band runs $9.58 to $19.98, and the latest print sits 43.9% under the top end of it. Holders are behind 40.4% over twelve months, and down 32.4% across the last three months.
On the chart it has slipped under both the 50-day ($12.41) and 200-day ($14.05) moving averages; RSI is 44, and the last 30 sessions moved at roughly 41% annualized volatility.
For ANNUAL, ended Dec 2025 it reported $475.68M in revenue, up 18.6% from a year earlier, with $78.33M of net profit (a 16.4% margin).
Buyers are paying 48.7 times trailing earnings. The median for its industry group is 29.3.
7 analysts follow the stock and the average call is "buy". The mean target, $16.30, sits 45.5% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper on P/E than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
7 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
CLBT is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $16.30, 45.5% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $10.88, so shares trade 2.9% above that estimate.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -1.2% | Bearish |
| Price vs 50-day average | -9.7% | Bearish |
| Price vs 200-day average | -20.3% | Bearish |
| 50-day vs 200-day | 50d below 200d | Bearish |
| RSI (14) | 44.2 | Bearish |
| MACD (12,26,9) | -0.31 | Bullish |
| Bollinger band position | 37% | Bearish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Oct 5, 2026 10:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 48.7x earnings, CLBT looks expensive against the market, and trades 66% above the 29.3x median among Software - Infrastructure names. The two comparisons do not always agree.
$11.20 is the latest print for CLBT, a move of +1.17% against yesterday's close of $11.07. Today's low and high so far: $10.97 and $11.34.
Equity value comes to $2.82B at the current price. By that measure it is number 2546 of the 3132 names in our coverage.
Buyers pay 48.7 times the last twelve months of profit (EPS $0.31).
The year's floor is $9.58 and the ceiling $19.98. Shares are 43.9% away from that ceiling.
Our data shows no dividend paid by Cellebrite over the trailing twelve months.
Of 7 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $16.30, with the most cautious at $12.50 and the most optimistic at $23.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on CLBT.